These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39032857)

  • 1. TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells.
    Abegunde SO; Grieve S; Reiman T
    Exp Hematol; 2024 Oct; 138():104282. PubMed ID: 39032857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
    Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
    Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
    Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloma cells self-promote migration by regulating TAB1-driven TIMP-1 expression in mesenchymal stem cells.
    Rethnam M; Tan DQ; Suda T
    Biochem Biophys Res Commun; 2021 Jan; 534():843-848. PubMed ID: 33183761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of TNF-alpha on TAZ expression and osteogenic potential of mesenchymal stem cells from myeloma patients].
    Li BZ; Shi MX; Li J; Ma J; Chen L; Chen B; Zhao CH
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):5-9. PubMed ID: 19538860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma.
    Li B; Shi M; Li J; Zhang H; Chen B; Chen L; Gao W; Giuliani N; Zhao RC
    Stem Cells Dev; 2007 Dec; 16(6):921-30. PubMed ID: 17927494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
    Mehdi SJ; Johnson SK; Epstein J; Zangari M; Qu P; Hoering A; van Rhee F; Schinke C; Thanendrarajan S; Barlogie B; Davies FE; Morgan GJ; Yaccoby S
    Br J Haematol; 2019 Feb; 184(4):578-593. PubMed ID: 30408155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma.
    Abegunde SO; Grieve S; Reiman T
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1879. PubMed ID: 37539777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells.
    Morgan JJ; McAvera RM; Crawford LJ
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma.
    Jin J; Cheng S; Wang Y; Wang T; Zeng D; Li Z; Li X; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1258-1266. PubMed ID: 31769473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanosignaling YAP/TAZ-TEAD Axis Regulates the Immunomodulatory Properties of Mesenchymal Stem Cells.
    Yoshii H; Kajiya M; Yoshino M; Morimoto S; Horikoshi S; Tari M; Motoike S; Iwata T; Ouhara K; Ando T; Yoshimoto T; Shintani T; Mizuno N
    Stem Cell Rev Rep; 2024 Jan; 20(1):347-361. PubMed ID: 37917410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes.
    Komatsu N; Kajiya M; Motoike S; Takewaki M; Horikoshi S; Iwata T; Ouhara K; Takeda K; Matsuda S; Fujita T; Kurihara H
    Stem Cell Res Ther; 2018 Dec; 9(1):342. PubMed ID: 30526677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from bone marrow mesenchymal stem cells promote proliferation and migration via upregulation yes-associated protein/transcriptional coactivator with PDZ binding motif expression in breast cancer cells.
    Wu W; Huang R; Ou L; Lei R
    Chin J Physiol; 2022; 65(5):233-240. PubMed ID: 36308078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
    Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
    Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.
    Wang S; Englund E; Kjellman P; Li Z; Ahnlide JK; Rodriguez-Cupello C; Saggioro M; Kanzaki R; Pietras K; Lindgren D; Axelson H; Prinz CN; Swaminathan V; Madsen CD
    Nat Cell Biol; 2021 Jul; 23(7):758-770. PubMed ID: 34226698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.
    Kim J; Denu RA; Dollar BA; Escalante LE; Kuether JP; Callander NS; Asimakopoulos F; Hematti P
    Br J Haematol; 2012 Aug; 158(3):336-46. PubMed ID: 22583117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics.
    Kuric M; Beck S; Schneider D; Rindt W; Evers M; Meißner-Weigl J; Zeck S; Krug M; Herrmann M; Hartmann TN; Leich E; Rudert M; Docheva D; Seckinger A; Hose D; Jundt F; Ebert R
    Cancer Res Commun; 2024 Apr; 4(4):1150-1164. PubMed ID: 38598843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
    Ren Z; Lantermans H; Kuil A; Kraan W; Arenzana-Seisdedos F; Kersten MJ; Spaargaren M; Pals ST
    J Hematol Oncol; 2021 Jan; 14(1):11. PubMed ID: 33436043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.